Digital PCR technology drives progress in early lung cancer diagnosis and personalized therapy
Dr. Gary Pestano, chief development officer at Biodesix, discusses how his team is leveraging Bio-Rad’s advanced Droplet Digital™ PCR (ddPCR™) technology to develop novel blood tests to aid the diagnosis and management of lung cancer. Pestano highlights the advantages of ddPCR over orthogonal technologies for circulating tumor DNA (ctDNA) analysis, the exciting pot...
